Navigation Links
Nanotech: A regulatory blueprint for the next administration

Washington, DC Nanotechnology will significantly change virtually every facet of the way we live. The next president has the opportunity to shape these changes and to ensure that nanotechnology's benefits will be maximized and its risks identified and controlled. A new report by former EPA official J. Clarence (Terry) Davies lays out a clear roadmap for the next presidential administration and describes the immediate and longer term steps necessary to deal with the current shortcomings of nanotechnology oversight.

"The future of the technology is in the hands of the incoming administration. The shape of the future will depend significantly on what the new government does," says Davies, whose report, Nanotechnology Oversight: An Agenda for the New Administration, was released today.

In the report Davies calls for the White House and federal agency policymakers to maximize the use of existing laws to improve nanotechnology oversight. Such measures include defining nanomaterials as "new" substances under federal toxics and food laws, thereby enabling the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) to consider the novel qualities and effects of nanomaterials. Davies also calls for federal pesticide and workplace safety laws to be used to protect against potential adverse impacts of nanomaterials.

Immediate policy changes, however, need to be followed by longer-term changes to existing oversight laws. For example, two major high-exposure applications of nanotechnology cosmetics and dietary supplements are essentially unregulated. The Federal Food, Drug and Cosmetic Act needs to be amended to deal with these applications. Other laws important to nanotechnology, such as the Toxic Substances Control Act and the Consumer Product Safety Act, also need radical revision, Davies says.

Without increased funding and staffing for relevant agencies many of the actions called for in the report will not be possible.

"In order to ensure the safe development of this rapidly advancing technology, which is projected will enable 15 percent of globally manufactured goods worth $2.6 trillion by 2014, there needs to be an increase in nanotechnology risk research monies in the fiscal year 2009 budget to $100 million and in FY 2010 to $150 million," says David Rejeski, the director of the Project on Emerging Nanotechnologies.

The report highlights the importance of creating sensible nanotechnology oversight policies that will help ensure the safe and sustainable application of nanotechnologies to climate change, food security, water purification, health care, and other pressing global problems.

"Potential risks of nanoscale materials have already been identified, and for the world to realize the benefits of this technology, the next administration must act swiftly and carefully," Rejeski says. "This will be a challenge, but one that could have limitless opportunities to improve the world in the 21st century."


Contact: Colin Finan
Project on Emerging Nanotechnologies

Related biology technology :

1. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
2. In Pain Market, Huge Unmet Needs, Tough Regulatory Environment Challenge Pharmaceutical Companies, According to MedPredict
3. ATS Medical Announces Canadian Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve
4. Neuftec Responds to a Fundamental Inaccuracy in Oxonica PLCs Regulatory Announcement
5. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
6. European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics Lung Cancer Drug
7. Regulatory Path for Bronchitol in Bronchiectasis
8. Huge Potential in Biosimilars if Generic Providers Overcome Regulatory Hurdles
9. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
10. Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
11. Biopure Completes U.K. Regulatory Agency Inspection
Post Your Comments:
(Date:11/30/2015)... , Dec. 1, 2015  An interventional radiology technique shows ... the preliminary results of a study being presented today at ... North America (RSNA). --> ... for decades by interventional radiologists as a way to stop ... procedure as a means of treating obesity is new. ...
(Date:11/30/2015)... /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") today ... to its Board of Directors to replace Dr. ... wealth of experience as co-founder of Resverlogix, with expertise in ... --> --> Dr. Wong remarked, "I am ... Zenith,s long standing expertise in epigenetics and the advanced stage ...
(Date:11/30/2015)... Florida , November 30, 2015 ... specializing in the development of innovative peptide and gene-based ... metastatic disease, today announced it will be presenting at ... on December 1, 2015 at 2.30 PM PT. Dr. ... and Strategic Advisor will be giving the presentation and ...
(Date:11/30/2015)... , Nov. 30, 2015  Northwest Biotherapeutics (NASDAQ: ... DCVax® personalized immune therapies for solid tumor cancers, announced ... additional independent director, and the Company welcomes Neil ... in a recent anonymous internet report on NW Bio.  ... Linda Powers stated, "We agree with ...
Breaking Biology Technology:
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/17/2015)... 17, 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ... and sale of broadly enabling, pressure cycling technology ("PCT")-based ... today announced it has received gross proceeds of $745,000 ... Placement (the "Offering"), increasing the total amount raised to ... additional closings are expected in the near future. ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
Breaking Biology News(10 mins):